A primary pancreatic carcinoid tumour with unusual clinical complaints: A case report

被引：4

作者：

Saint-Marc O. ^{[1
]}

Cogliandolo A. ^{[1
]}

Pozzo A. ^{[1
]}

Pidoto R.R. ^{[1
]}

机构：

[1] Serv. de Chir. Digest./Endocrinienne, Hospital de la Source, 45067 Orléans Cedex 2

来源：

World Journal of Surgical Oncology | / 2卷 / 1期

关键词：

Carcinoid; Pancreas;

D O I：

10.1186/1477-7819-2-3

中图分类号：

学科分类号：

摘要：

Background: Unless metastatic or compressing the pancreatic duct, carcinoid of the pancreas are asymptomatic showing normal levels of serotonine and its metabolites in plasma and urine, thus resulting in delayed diagnosis and a consequent poor prognosis. However, if resection is timely accomplished, no local recurrence might be encountered and a normal survival might be expected in the absence of metastatic disease. Case Presentation: The reported case of pancreatic carcinoid tumour in a 62-year-old woman reporting only atypical symptoms consisting of intermittent epigastric pain and nausea. Urinary 5-hydroxyindolacetic acid levels were within normal limits and only a slight elevation of serum serotonine level was detected on admission. After tumour localisation with endoscopic ultrasonography, left splenopancreasectomy with splenic, celiac and hepatic lymphadenectomy was carried out. Conclusion: The role of endoscopic ultrasonography in early detection and precise localisation of pancreatic carcinoids, as well as the role of somatostatin-receptor scintigraphy with ?111Indium labelled pentreotide in excluding distant metastases, are confirmed. The radical resection with lymphadenectomy is recommended in order to have a precise histological examination and detect occult lymph node metastases. © 2004 Saint-Marc et al; licensee BioMed Central Ltd.

引用

页数：4

共 19 条

[1]

Buchanan K.D., Johnston C.F., O'Hare M.M., Ardill J.E., Shaw C., Collins J.S., Watson R.G., Atkinson A.B., Hadden D.R., Kennedy T.L., Et al., Neuroendocrine tumours. A European view, Am. J. Med., 81, SUPPL. 6B, pp. 14-22, (1986)

[2]

Modlin I.M., Sandor A., An analysis of 8305 cases of carcinoid tumours, Cancer, 15, pp. 813-829, (1997)

[3]

Feldman J.M., Carcinoid tumour and the carcinoid syndrome, Curr. Probl. Surg., 26, pp. 835-885, (1989)

[4]

Creutzfeldt W., Endocrine tumours of the pancreas, The Diabetic Pancreas, pp. 543-586, (1985)

[5]

Eusebi V., Capella C., Bondi A., Sessa F., Vezzadini P., Mancini A.M., Endocrine pancreatic cells in pancreatic exocrine carcinomas, Histopathology, 5, pp. 599-613, (1981)

[6]

Capella C., Heitz P.U., Hoefler H., Solcia E., Kloeppel G., Revised classification of neuroendocrine tumours of the lung, pancreas and gut, Virchows. Arch., 425, pp. 547-560, (1995)

[7]

Maurer C.A., Baer H.U., Dyong T.H., Mueller-Garamvoelgyi E., Friess H., Ruchti C., Reubi J.C., Buchler M.W., Carcinoid of the pancreas: Clinical characteristics and morphological features, Eur. J. Cancer, 7, pp. 1109-1116, (1996)

[8]

Godwin J.D., Carcinoid tumours. An analysis of 2837 cases, Cancer, 36, pp. 560-569, (1975)

[9]

Berge T., Linell F., Carcinoid tumours. Frequency in a defined population during a 12-year-period, Acta Pathol. Microbiol. Scand. [a], 844, pp. 322-330, (1976)

[10]

Williams E.D., Sandler M., The classification of carcinoid tumours, Lancet, 1, pp. 238-239, (1963)

← 1 2 →